Month: February 2024

UPSTACK Acquires CA Communications’ Telecom Services Division

Written by Customer Service on February 29, 2024. Posted in Mergers And Acquisitions.

Founder Marc Agar to Join UPSTACK’s Fast-Growing Platform as a Partner NEW YORK, Feb. 29, 2024 (GLOBE NEWSWIRE) — UPSTACK, the fastest-growing platform for digital infrastructure, announced today that it has acquired the telecom agency services division of CA Communications Inc., based in Wayzata, Minnesota. CA Communications’ Founder, President and CEO Marc Agar will become an UPSTACK Partner while remaining CA’s chief executive. The terms of the transaction were not disclosed. Going forward, CA’s agency business will operate under the UPSTACK brand with ongoing support from key CA personnel—including Marc Agar and CA Partner Michael Agar—alongside enhanced resources from UPSTACK. CA Communications will continue to operate its technology resale and managed services lines of businesses under the CA Communications brand. “Marc Agar...

Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance

Written by Customer Service on February 29, 2024. Posted in Earnings Releases And Operating Results.

Full-Year 2023 Total Revenue Growth of 20% to $197.5 Million, with Adjusted EBITDA Growth of 40% Fourth Quarter Total Revenue Growth of 23% to $65.0 Million, with Adjusted EBITDA Growth of 50% Fourth Quarter Gross Margin of 75% and Adjusted EBITDA Margin of 34% Full-Year 2024 Total Revenue Guidance of $237 to $241 Million Conference Call Today at 8:30am Eastern Time CAMBRIDGE, Mass., Feb. 29, 2024 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today reported financial results and business highlights for the fourth quarter and year ended December 31, 2023, and provided full-year 2024 financial guidance. Fourth Quarter 2023 Financial HighlightsTotal net revenue increased 23% to $65.0 million MACI® net revenue growth of 22% to $56.7 million Burn...

Great Elm Capital Corp. Announces Fourth Quarter and Full Year 2023 Financial Results

Written by Customer Service on February 29, 2024. Posted in Earnings Releases And Operating Results.

Company to Host Conference Call and Webcast at 8:30 AM ET Today PALM BEACH GARDENS, Fla., Feb. 29, 2024 (GLOBE NEWSWIRE) — Great Elm Capital Corp. (“we,” “our,” the “Company” or “GECC,”) (NASDAQ: GECC), a business development company, today announced its financial results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter and Other Recent Highlights:In February 2024, the Company raised $24 million of equity at Net Asset Value from a special purchase vehicle (“SPV”), supported by a $6 million investment by Great Elm Group (“GEG”) into the SPV. Net investment income (“NII”) for the quarter ended December 31, 2023 was $3.3 million, or $0.43 per share, as compared to $3.1 million, or $0.40 per share, for the quarter ended September 30, 2023.Fourth consecutive quarter of NII more than covering the base...

GH Research Reports Full Year 2023 Financial Results and Provides Business Updates

Written by Customer Service on February 29, 2024. Posted in Earnings Releases And Operating Results.

Phase 2b clinical trial of GH001 in patients with treatment-resistant depression on track for expected completion of double-blind phase in Q3 2024 Phase 2a clinical trial of GH001 in postpartum depression on track for expected completion in Q3 2024 Successfully completed Phase 1, dose-ranging clinical pharmacology trial of intravenous GH002 in healthy volunteers Additional patents granted in Europe Cash, cash equivalents, other financial assets and marketable securities of $222.7 million expected to provide cash runway into 2026DUBLIN, Ireland, Feb. 29, 2024 (GLOBE NEWSWIRE) — GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today reported financial results for the year ended December 31, 2023, and provided updates on...

Vertex Announces Fourth Quarter and Full Year 2023 Financial Results

Written by Customer Service on February 29, 2024. Posted in Earnings Releases And Operating Results.

KING OF PRUSSIA, Pa., Feb. 29, 2024 (GLOBE NEWSWIRE) — Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a leading global provider of indirect tax solutions, today announced financial results for its fourth quarter and full year ended December 31, 2023. “The Vertex execution engine delivered exceptionally strong financial results in the fourth quarter,” stated David DeStefano, President, Chief Executive Officer, and Chairperson of the Board. “Our year-over-year revenue growth increased to 18.1%, the highest we’ve achieved since becoming a public company. Moreover, our cash provided by operating activities increased by over 16% compared to 2022, and we generated our strongest quarterly free cash flow in over three years, resulting in positive free cash flow for the full year. We believe this robust finish to the year...

Else to Showcase First-in-Kind Whole-Food Plant-Based Ready-to-Drink Kids Nutritional Shakes at Natural Products EXPO WEST® 2024

Written by Customer Service on February 29, 2024. Posted in Public Companies.

Else Announces Soft Launch of its Adult Ready-to-Drink Product; Taste Testing to be Available during EXPO WEST at Booth #N239 VANCOUVER, British Columbia, Feb. 29, 2024 (GLOBE NEWSWIRE) — ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) (“Else” or the “Company”), today announced that it will be showcasing its whole-food, plant-based, dairy-free and soy-free kids Ready-to-Drink (RTD) nutritional shakes at Natural Products EXPO WEST® 2024 being held March 13 through March 15, 2024 in Anaheim, California. The Company also plans to have a soft launch of its Adult RTD nutritional product at the event with taste testing available. The Else booth is #N239 located in the North Halls of the Anaheim Convention Center in Anaheim, California. Else’s kids RTD product is the first of its kind, and only whole food based...

Evaxion to Host R&D Day on March 19, 2024, Highlighting its Latest Technology Innovations

Written by Customer Service on February 29, 2024. Posted in Public Companies.

COPENHAGEN, Denmark, Feb. 29, 2024 (GLOBE NEWSWIRE) — Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today announces that it will host a Research & Development (R&D) Day focusing on its core AI-Immunology™ platform on March 19, 2024, at 14:00 – 18:00 CET / 8:00 a.m. – 12:00 a.m. EST. The R&D Day will feature a series of talks from Evaxion’s scientists and bioinformaticians, providing insights into Evaxion’s validated AI-Immunology™ platform for vaccine target discovery, design and development. The event will highlight the unique predictive capabilities that differentiate the platform and how these can help address severe unmet medical needs for patients with cancer and infectious...

Terranet provides update on prototype tests in lab during the first quarter

Written by Customer Service on February 29, 2024. Posted in Public Companies.

Terranet AB (publ) today announces that the Company is performing prototype tests in a lab environment in accordance with the previously communicated timetable. The purpose of the lab tests is to verify updated conceptual solutions of our prototype, which is a preparatory step for the upcoming prototype demo in cars during the second quarter this year. Initially, the tests have delivered positive data, which means that the conditions for a successful prototype demo in a car during the second quarter have been further strengthened. The lab tests continue in order to refine relevant measurements in areas such as object identification, object classification and reaction time. The company intends to report back with an outcome after the first quarter’s prototype tests. Magnus Andersson, CEO of Terranet, comments “It is pleasing...

MariMed Introduces New and Improved Vibations™ Cannabis and Electrolyte Drink Mix

Written by Customer Service on February 29, 2024. Posted in Public Companies.

NORWOOD, Mass., Feb. 29, 2024 (GLOBE NEWSWIRE) — Vibations, the cannabis and electrolyte drink mix that delivers advanced hydration, has released several new flavors and has been re-formulated to deliver a faster acting 15-minute onset. Perfect for any on-the-go activity, Vibations provides a replenishing boost of focus and energy from its core formula of full-spectrum cannabis and hydrating electrolytes. Joining the original line-up of four flavors are two new caffeine-free options and a third new flavor designed to deliver a better night’s sleep to recharge for the next day. Vibations is developed and distributed by multi-state cannabis operator MariMed Inc. (“MariMed”) (CSE: MRMD) (OTCQX: MRMD). The complete Vibations line-up now features seven flavors, each made with all-natural ingredients, no artificial colors or flavors,...

Metasphere Labs Inc. Announces Successful Name Change and New Stock Ticker Symbol Activation

Written by Customer Service on February 29, 2024. Posted in Public Companies.

VANCOUVER, British Columbia, Feb. 29, 2024 (GLOBE NEWSWIRE) — Metasphere Labs Inc. (formerly Looking Glass Labs Ltd., “Metasphere” or the “Company“) (Cboe Canada: LABZ) (OTC: LABZF) (FRA: H1N) is thrilled to announce the successful completion of its corporate name change from Looking Glass Labs Ltd. to Metasphere Labs Inc. As of today, the Company’s new stock ticker symbol “LABZ” is also active on the Cboe Canada. This milestone marks a significant step in the Company’s evolution and its renewed commitment towards developing Web3 applications with a positive impact on our planet. The transition to Metasphere reflects the Company’s broader vision and dedication to leveraging the latest in blockchain technology to foster sustainable and impactful solutions across various sectors. With...

Month: February 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice